Literature DB >> 30583639

[Retrospective analysis and discussion on 74 cases of adverse reactions of traditional Chinese medicine injection].

Yan Wang1, Li-Ping Fan1, Ju Song2, Yue-Ping Cai1, Ting-Ting Jinang1, Yu-Guang Wang1, Xiang-Wen Kong1, Jia-Rui Wu3.   

Abstract

As a modern dosage form drug with rapid effect, traditional Chinese medicine (TCM) injection has been more and more used in clinical practice. Meanwhile the safety of TCM injection has attracted more and more attention. The retrospective analysis on 74 cases of adverse reaction of TCM injections collected from 2007 to 2016 in the Third Affiliated Hospital of Beijing University of Chinese Medicine showed that the proportion of men and women with adverse reactions was 0.54:1; the average age was 62.5 years old; 21 kinds of TCM injections were involved. Among them, the most reported were blood-regulating agents. The top four kinds of TCM injections with highest adverse drug reactions (ADRs) were Tanreqing injection, Danhong Injection, Shuxuening Injection and Xuesaitong for injection. The top three clinical manifestations of adverse reactions were lesions of skin and its appendages, damage of circulatory system and damage of nervous system. The potential causes of the adverse reactions of TCM injections were analyzed, and it was believed that individual difference, medicine, pharmaceutical excipients, solvent and TCM syndrome differentiation may be the main five causes for the adverse reactions of TCM injections. In order to reduce the adverse reactions of TCM injections, it is suggested that the clinical pharmacists should participate in the application management of TCM injections in the hospital; the production enterprises shall strengthen the whole life cycle management of the drugs; and at the same time, the drug control and administration authorities should improve the drug management methods constantly and encourage the development of TCM injections to the high quality level. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  adverse drug reaction(ADR) ; reason ; retrospective analysis ; traditional Chinese medicine(TCM) injection

Mesh:

Substances:

Year:  2018        PMID: 30583639     DOI: 10.19540/j.cnki.cjcmm.20180815.004

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Macromolecular substances as a dangerous factor in traditional Chinese medicine injections were determined by size-exclusive chromatography.

Authors:  Yue Li; Jinlian Duan; Heng Xia; Bin Shu; Weigang Duan
Journal:  Toxicol Res (Camb)       Date:  2020-05-21       Impact factor: 3.524

2.  Untargeted Safety Pharmacology Screen of Blood-Activating and Stasis-Removing Patent Chinese Herbal Medicines Identified Nonherbal Ingredients as a Cause of Organ Damage in Experimental Models.

Authors:  Xinyan Liu; Rui Shao; Xinyue Yang; Guangxu Xiao; Shuang He; Yuxin Feng; Yan Zhu
Journal:  Front Pharmacol       Date:  2019-09-12       Impact factor: 5.810

3.  Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis.

Authors:  Sun Yawei; Long Jianhai; Zhao Junxiu; Peng Xiaobo; Qiu Zewu
Journal:  BMC Pharmacol Toxicol       Date:  2021-05-03       Impact factor: 2.483

4.  Comparative Efficacy of Chinese Herbal Injections for Septic Shock: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Peiying Huang; Yan Chen; Haobo Zhang; Bojun Chen; Shuai Zhao; Yuchao Feng; Sisi Lei; Qihua Wu
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

5.  Safety of Using Traditional Chinese Medicine Injections in Primary Medical Institutions: Based on the Spontaneous Reporting System 2016-2020 in Henan Province, China.

Authors:  Ziqi Yan; Zhanchun Feng; Zhiming Jiao; Ganyi Wang; Chaoyi Chen; Da Feng
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

6.  Pharmacokinetics of baicalin and oroxyloside in plasma and different tissues of rats after transnasal aerosol inhalation and intravenous injection of Tanreqing.

Authors:  Teng-Fei Chen; Ling Song; Yun-Hang Gao; Han Li; Jian-Liang Li; Hong-Ping Hou; Bo Peng; Hui-Ying Wang; Wen-Hao Cheng; Zu-Guang Ye; Ying-Fei Li; Guang-Ping Zhang
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.